CAMBRIDGE, England–Linguamatics Ltd, a leader in enterprise text mining for the life science and other markets, today announced that it has joined the Microsoft BioIT Alliance, an association of life science organizations and informatics companies whose focus is to enhance collaboration and accelerate the pace of drug discovery and development.
“As the amount of textual information impacting drug discovery and development programs grows exponentially each year, the ability to extract and share decision-relevant knowledge is crucial to streamline the process and raise productivity,” said Roger Hale, COO and Co-founder of Linguamatics. “Linguamatics is delighted to be part of Microsoft’s BioIT Alliance. As a leader in knowledge discovery from text, we look forward to working with other alliance members to explore new ways in which the immense value of text mining can be exploited across complex, multidisciplinary organizations like pharmaceutical companies.”
“We are very pleased to welcome Linguamatics to the BioIT Alliance,” said Rudy Potenzone, Worldwide Industry Technology Strategist for Pharmaceuticals at Microsoft and BioIT Alliance Coordinator. “Their commitment to innovation coupled with world-class experience and expertise in discovering and extracting relevant facts and relationships from text across the enterprise complements the capabilities of other Alliance members.”
The BioIT Alliance is designed to enable collaboration among organizations in the life sciences field in order to shorten the time between discovery of new biological data and the application of that knowledge to human health.
ABOUT THE BIOIT ALLIANCE
Formed in 2006, the BioIT Alliance is a cross-industry group working to integrate science and technology in order to accelerate the pace of drug discovery and realize the potential of personalized medicine. Founding members include Accelrys Software Inc., Affymetrix, Inc., Agilent Technologies Inc., Amylin Pharmaceuticals, Inc., Applied Biosystems, The BioTeam Inc., Digipede Technologies LLC, Discovery Biosciences Corporation, Geospiza Inc., Hewlett-Packard Development Company, L.P., Illumina Inc., InterKnowlogy, Microsoft Corporation, Sun Microsystems Inc., The Scripps Research Institute, VizX Labs LLC and other key companies in the pharmaceutical, biotech, hardware and software industries. Additional information about the BioIT Alliance can be found on the BioIT Alliance Web site at http://www.bioitalliance.org.
Linguamatics helps organizations to maximize the value derived from information resources through effective deployment of innovative natural language processing (NLP) based technology. The versatile interactive information extraction system, I2E, helps organizations to do much more than simply cope with vast quantities of information. Its unique combination of search and text mining helps organizations to turn this information into a competitive advantage. From life sciences and healthcare to business intelligence, from media analysis to security, users mine large collections of documents, extracting relevant facts, relationships and quantitative data from content such as scientific papers, news feeds, patents, or internal reports. Linguamatics has a rapidly growing user community with I2E deployed at most top-10 pharma companies. The company was founded in 2001, and has headquarters in Cambridge, UK.
For further information on Linguamatics products and solutions, visit www.linguamatics.com.
The Linguamatics logo is a trademark of Linguamatics Ltd. All rights reserved. All other trademarks mentioned in this document are the property of their respective owners.